eTMF applications are modernizing clinical trial processes.
Cancer Research UK’s Centre for Drug Development decided to implement an eTMF system to reduce costs, improve quality, and enhance process efficiencies.
After approving the business case, Cancer Research UK was able to move quickly, implementing the validated system “out of the box” within six weeks.
The Veeva eTMF system has delivered on Cancer Research UK’s goals of providing a return on investment in less than five years, improving quality by maintaining study eTMFs in a permanent inspection ready state, and achieving greater productivity with active TMF management.
Modernizing Clinical Trial Processes to Bring Novel Cancer Therapies to Patients Faster
Did you know that industry leaders in clinical are gathering on at Veeva R&D and Quality Summit? Pre-register your interest for 2022 Veeva R&D and Quality Summit.